MoneyWorks4Me

Phaarmasia - Quaterly Results

07 Feb 2026 Evaluate
The total revenue hovered 239.92% to Rs. 160.51 millions for the December 2025 quarter as against Rs. 47.22 millions during the corresponding quarter last year.The Total Profit for the quarter ended December 2025 of Rs. 162.74 millions grew from Rs.-7.00 millions Operating profit Margin for the quarter ended December 2025 improved to 10.00% as compared to -6.04% of corresponding quarter ended December 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 160.51 47.22 239.92 394.76 189.39 108.44 243.69 305.93 -20.34
Other Income 1.62 1.90 -14.74 6.17 5.63 9.59 7.46 6.62 12.69
PBIDT 10.00 -6.04 -265.56 31.58 -8.36 -477.75 -12.67 -1.58 701.90
Interest 0.18 0.08 125.00 0.46 0.14 228.57 0.16 0.44 -63.64
PBDT 199.77 -6.12 -3364.22 221.07 -8.50 -2700.82 -12.83 -2.02 535.15
Depreciation 0.61 0.82 -25.61 1.80 2.41 -25.31 3.20 3.44 -6.98
PBT 199.16 -6.94 -2969.74 219.27 -10.91 -2109.81 -16.03 -5.46 193.59
TAX 36.42 0.06 60600.00 36.47 -0.26 -14126.92 -0.13 -0.28 -53.57
Deferred Tax -0.68 0.06 -1233.33 -0.63 -0.26 142.31 -0.13 -0.28 -53.57
PAT 162.74 -7.00 -2424.86 182.80 -10.65 -1816.43 -15.90 -5.18 206.95
Equity 68.27 68.27 0.00 68.27 68.27 0.00 68.27 68.27 0.00
PBIDTM(%) 6.23 -12.79 -148.71 8.00 -4.41 -281.23 -5.20 -0.52 906.62
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..